NASDAQ$HLVX

HilleVax Inc · Q2 2022 earnings

Q2 2022 earnings · · Investor relations

Headline financials

EPS (adj)

-$2.03

Previous: -$0.47-332.2%
Net Income

-$95.1M

Previous: -$1.67M-5601.9%
Operating Income

-$12.8M

Previous: -$1.21M-955.9%
Cash & Equivalents

$315M

No prior period
Total Assets

$341M

No prior period
Stock-Based Comp

$556K

No prior period

Revenue & EPS history

HilleVax · Revenue · Quarterly

$0

Q1 2025

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 6 quarterly earnings reports

Historical avg

-3.3%

Avg return

Earnings day

-2.3%

Avg return

5 days after

-0.9%

Avg return

30 days after

22%

4 / 18 earnings

Positive

+7.9%

Q4 2024

Best reaction

-16.7%

Q2 2023

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q3 2025
Q2 2025+0.5%+0.5%+2.0%
Q1 2025-1.0%-5.6%-6.7%
Q4 2024+7.9%-10.1%+17.0%
Q3 2024-2.6%+1.6%+2.6%
Q2 2024-0.6%+5.7%+8.2%
Q1 2024+2.7%-3.0%+0.2%
Q4 2023-9.0%-5.4%-29.5%
Q3 2023+1.5%
Q2 2023-16.7%
Q1 2023-1.2%
Q4 2022-12.1%
Q3 2022-8.2%
Q3 2021-8.2%
Q2 2021-6.5%
Q2 2022-6.5%
Q1 2022+0.0%
Q1 2021+0.0%
Q4 2021+0.0%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro